Literature DB >> 26052801

Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.

Daisuke Hoshi1, Eiichi Tanaka1, Ataru Igarashi2, Eisuke Inoue1, Akiko Kobayashi1, Naoki Sugimoto1, Kumi Shidara1, Eri Sato1, Yohei Seto1, Ayako Nakajima1, Shigeki Momohara1, Atsuo Taniguchi1, Kiichiro Tsutani2, Hisashi Yamanaka1.   

Abstract

OBJECTIVE: Along with the advances of newly developed medical therapies in rheumatoid arthritis (RA), the number of pharmacoeconomical issues has been paid attention rapidly. For cost-utility analysis and determination of quality-adjusted life years, measurement of the EuroQol 5-dimensional descriptive system (EQ-5D) is essential, and has been used in several clinical studies. However, EQ-5D utility measure in Japanese patients with RA, especially in daily practice has not been fully documented. We analyzed the distribution of EQ5D utility scores and investigated the relationship between other clinical measures based on our Institute of Rheumatology, Rheumatoid Arthritis (IORRA) database.
METHOD: Among 5,284 outpatients who participated in the IORRA cohort study on October 2007, data from 5,043 patients who completed the EQ-5D questionnaire were cross-sectionally analyzed. EQ-5D scores in each subgroup for baseline feature such as gender, age, disease activity score 28 (DAS28), and Japanese version of health assessment questionnaire (J-HAQ) were evaluated. For the evaluation of variables that influenced EQ-5D score, the contribution of each variable was evaluated by ANOVA.
RESULTS: Average EQ-5D score was 0.76 in 5,284 patients (84% females, average age: 59.0 years, average disease duration: 12.4 years) whose average DAS28 was 3.3 and average J-HAQ was 0.74. EQ-5D scores were highly correlated with J-HAQ and DAS28, and were significantly lower in females and rheumatoid factor-positive patients. Older age, longer disease duration, higher DAS28, and higher J-HAQ were also significantly associated with lower EQ-5D scores. In multivariate analysis, the factor that most strongly influenced EQ-5D was J-HAQ (57.6%), followed by pain visual analog score (VAS; 12.5%).
CONCLUSION: This study clearly demonstrated the distribution of EQ-5D score in the daily practice of RA patients, and provides important information for the pharmacoeconomical studies in rheumatology.

Entities:  

Keywords:  EQ-5D; Health assessment questionnaire; Health-related quality of life; Rheumatoid arthritis; Utility index

Mesh:

Year:  2015        PMID: 26052801     DOI: 10.3109/14397595.2015.1059983

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  7 in total

1.  Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study.

Authors:  Tsutomu Takeuchi; Ryo Nakajima; Shuichi Komatsu; Kiyotaka Yamazaki; Tomohiro Nakamura; Naoki Agata; Ataru Igarashi; Toshiro Tango; Yoshiya Tanaka
Journal:  Adv Ther       Date:  2017-01-31       Impact factor: 3.845

2.  Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.

Authors:  Merita Qorolli; Blerta Rexhepi; Sylejman Rexhepi; Matej Mustapić; Ines Doko; Simeon Grazio
Journal:  Rheumatol Int       Date:  2019-03-07       Impact factor: 2.631

3.  Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population.

Authors:  Thomas Patton; Hao Hu; Luan Luan; Keqin Yang; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2018-07-04       Impact factor: 4.147

4.  Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.

Authors:  Takefumi Furuya; Koei Oh; Katsunori Ikari; Eisuke Inoue; Eiichi Tanaka; Hisashi Yamanaka; Masayoshi Harigai
Journal:  Clin Rheumatol       Date:  2021-09-29       Impact factor: 2.980

Review 5.  The Use of patient Reported Outcome Measures for Rheumatoid Arthritis in Japan: A Systematic Literature Review.

Authors:  Ann Chuo Tang; Hyunchung Kim; Bruce Crawford; Taeko Ishii; Tamas Treuer
Journal:  Open Rheumatol J       Date:  2017-04-28

6.  Health-related quality of life in patients with rheumatoid arthritis.

Authors:  Wanruchada Katchamart; Pongthorn Narongroeknawin; Wanwisa Chanapai; Phakhamon Thaweeratthakul
Journal:  BMC Rheumatol       Date:  2019-08-14

7.  Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry.

Authors:  Toshifumi Fujiwara; Masakazu Kondo; Hisakata Yamada; Akihisa Haraguchi; Kenjiro Fujimura; Koji Sakuraba; Satoshi Kamura; Jun-Ichi Fukushi; Hisaaki Miyahara; Yasushi Inoue; Tomomi Tsuru; Toshihide Shuto; Seiji Yoshizawa; Eiichi Suematsu; Tomoya Miyamura; Masahiro Ayano; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Masanobu Ohishi; Akie Hirata; Shoji Tokunaga; Atsushi Takada; Daisuke Hara; Hidetoshi Tsushima; Yukio Akasaki; Satoshi Ikemura; Takuya Sueishi; Masakazu Toya; Takahide Sakuragi; Tomoko Tsutsui; Kazuhiro Kai; Shinkichi Arisumi; Yasuharu Nakashima
Journal:  Arthritis Res Ther       Date:  2022-02-22       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.